Acadia Healthcare (ACHC) Tops Q4 EPS by 6c; offers guidance

Acadia Healthcare (NASDAQ: ACHC) reported Q4 EPS of $0.85, $0.06 better than the analyst estimate of $0.79. Revenue for the quarter came in at $742.8 million versus the consensus estimate of $727.6 million.

GUIDANCE:

Acadia Healthcare sees Q1 2024 EPS of $0.78-$0.83, versus the consensus of $0.81. Acadia Healthcare sees Q1 2024 revenue of $775-785 million, versus the consensus of $768.8 million.

Acadia Healthcare sees FY2024 EPS of $3.40-$3.70, versus the consensus of $3.70. Acadia Healthcare sees FY2024 revenue of $3.18-3.25 billion, versus the consensus of $3.215 billion.

For earnings history and earnings-related data on Acadia Healthcare (ACHC) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Stifel Starts Victrex Plc. (VCT:LN) (VTXPF) at Buy
• RBC Capital Starts Molina Healthcare (MOH) at Sector Perform